John Kapoor, founder of Insys Therapeutics. Photo: Boston Globe/Getty Images
Alec Burlakoff, the former sales executive for Arizona-based Insys Therapeutics, admitted in federal court on Friday that he was directed to enlist and bribe physicians to boost sales of the company's fentanyl-based pain drug, reports NBC.
Driving the news: In wrapping up the fifth week of the nation's first federal trial spotlighting Big Pharma leadership, founder John Kapoor and the 4 other former Insys executives on trial continue to claim their innocence. Evidence included a music video Burkaloff — who pleaded guilty in November — made, featured employees pitching doctors to prescribe their drug, Subsys.
Go deeper: The implications of the opioid lawsuits